Vivet Therapeutics' CEO, Jean-Philippe Combal
PARIS, France June 12th, 2018, Vivet Therapeutics, a biotechnology company developing novel gene therapies for rare
Vivet's CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1x1 meetings during BIO 2018 in Boston on June 4-7.
Vivet Therapeutics announces 2 presentations on its lead product
Vivet Therapeutics' CEO, Jean-Philippe Combal
Vivet Therapeutics announces presentation on its lead product at the upcoming
Vivet is a gold sponsor of the
ean-Philippe Combal, Vivet Therapeutics' CEO
Jean-Philippe Combal, Vivet Therapeutics' CEO
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2017 London Healthcare Conference on…